Is there a generic Wegovy?

If you have searched for a more affordable version of Wegovy, you have probably come across claims about “generic semaglutide” or “compounded Wegovy alternatives.” The short answer: there is no generic Wegovy. And the products marketed as alternatives are not the same thing — in ways that matter for your safety.

This guide explains why no generic exists, what compounded semaglutide actually is, and how you can access the real medication affordably.

No generic Wegovy exists

Wegovy (semaglutide 2.4 mg) is manufactured by Novo Nordisk and is protected by multiple patents that extend into the mid-2030s. Until those patents expire, no pharmaceutical company can legally produce a generic bioequivalent version of semaglutide.

Generic medications must go through a rigorous FDA approval process known as an Abbreviated New Drug Application (ANDA). The generic manufacturer must demonstrate that their product contains the same active ingredient, in the same dosage form and strength, and that it performs identically in the body. None of this is possible while patent protections remain in place.

What is semaglutide?

Semaglutide is the active pharmaceutical ingredient in both Wegovy and Ozempic. It is a GLP-1 receptor agonist — a class of medication that mimics a natural hormone involved in appetite regulation, blood sugar control, and gastric emptying. Understanding that semaglutide is the ingredient, not the brand, is important for evaluating the claims you see online.

Novo Nordisk developed and patented semaglutide. The company markets it under two brand names for two distinct FDA-approved indications:

• Wegovy — FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
• Ozempic — FDA-approved for the treatment of type 2 diabetes

Both are injectable semaglutide, but they are prescribed at different doses and for different clinical purposes. An oral formulation, Rybelsus, is also FDA-approved for type 2 diabetes, but there is no other injectable semaglutide product on the market.

Compounded semaglutide is not a generic

This is the most critical distinction patients need to understand. Compounded semaglutide — the product offered by many online clinics and telehealth platforms — is not a generic version of Wegovy. It is a fundamentally different category of product.

A true generic medication must meet the same FDA standards as the original brand-name drug. It must contain the same active ingredient in the same form, at the same strength, and must be manufactured in FDA-inspected facilities under strict quality controls. Compounded medications meet none of these requirements.

Compounding pharmacies mix medications on a per-patient basis. While compounding serves a legitimate role in medicine — such as creating custom dosage forms for patients who cannot swallow pills — compounded semaglutide is being used to circumvent the patent and pricing structure of a brand-name drug. This is a very different use case, and it comes with real risks.

Risks of compounded semaglutide

The FDA has issued multiple warnings about compounded semaglutide products. The risks are not theoretical — adverse events have been reported, and the agency has taken enforcement actions against specific compounding pharmacies. Here are the primary concerns:

• Semaglutide salt forms. Some compounding pharmacies use semaglutide sodium or semaglutide acetate rather than the semaglutide base used in Wegovy. These different salt forms have not been tested in clinical trials and may behave differently in the body. The FDA has stated that products containing semaglutide salt forms are not interchangeable with Wegovy or Ozempic.
• Dosing inconsistencies. Without FDA-regulated manufacturing processes, compounded products may contain more or less semaglutide than labeled. Overdosing can cause severe gastrointestinal side effects, while underdosing means the medication may not work at all.
• Sterility and contamination. Injectable medications must be prepared under strict sterile conditions. Compounding pharmacies are not held to the same manufacturing standards as FDA-approved facilities. Contaminated injectables can cause serious infections.
• No clinical trial data. Wegovy’s FDA approval is based on the STEP clinical trial program, which enrolled thousands of patients and demonstrated both efficacy and safety. Compounded semaglutide has no equivalent evidence base.

Why PEAK only uses FDA-approved medications

At PEAK Wellness & Aesthetics, we exclusively prescribe FDA-approved brand-name semaglutide. This is not a business decision — it is a clinical one. Our patients deserve the same medication that was rigorously tested in large-scale clinical trials, manufactured under the strictest quality controls, and approved by the FDA for their specific condition.

When you receive Wegovy through PEAK, you know exactly what you are getting: the correct molecule, at the correct dose, in a pre-filled injection pen that has been manufactured in an FDA-inspected facility. There is no ambiguity about the salt form, the concentration, or the sterility of the product.

Affording brand-name Wegovy

We understand that cost is often the reason patients consider compounded alternatives. Wegovy’s list price is significant, and not every insurance plan covers it. But there are several pathways to make brand-name treatment accessible — and our team helps you work through every one of them.

Manufacturer savings cards

Novo Nordisk offers savings programs that can substantially reduce out-of-pocket costs for commercially insured patients. Eligible patients may pay as little as $0 for their first fills, with ongoing monthly savings thereafter. Our team helps you apply and ensures your pharmacy processes the card correctly.

Insurance coverage and prior authorization

Many commercial insurance plans now cover Wegovy for weight management. Coverage often requires a prior authorization, which means your clinician must submit documentation showing that the medication is medically necessary. At PEAK, we handle the entire prior authorization process for you — including appeals if your initial request is denied.

The real cost of cutting corners

It is worth considering what you are actually saving when you choose a compounded product. If the medication is underdosed, you are paying for something that does not work. If it causes an adverse event due to contamination or incorrect salt forms, the medical costs of treating that complication can far exceed any savings. And if the product is effective but you have no clinical monitoring, you are missing the clinical care that makes weight loss sustainable.

At PEAK, we believe that safe, effective weight loss treatment should be accessible. That is why we invest the time to help every patient find the most affordable path to FDA-approved medication, rather than steering anyone toward unregulated alternatives.

Important safety information: Wegovy carries a boxed warning about thyroid C-cell tumors (medullary thyroid carcinoma) based on animal studies. It is contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Discuss your full medical history with your clinician before starting treatment.

The PEAK Clinical Team

PEAK Wellness & Aesthetics

Evidence-based guidance from our board-certified clinicians specializing in medical weight loss and obesity medicine.